Imaging and biodistribution of radiolabeled SP90 peptide in BT-483 tumor bearing mice.
Animals
Breast Neoplasms
/ diagnosis
Cell Line, Tumor
Female
Gallium Radioisotopes
/ pharmacokinetics
Heterocyclic Compounds, 1-Ring
/ metabolism
Humans
Indium Radioisotopes
/ pharmacokinetics
Mice
Mice, Inbred NOD
Mice, SCID
Multimodal Imaging
Oligopeptides
/ chemistry
Radiopharmaceuticals
/ chemistry
Tissue Distribution
Xenograft Model Antitumor Assays
BT-483
DOTA-SP90
nanoPET/CT
nanoSPECT/CT
Journal
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
ISSN: 1872-9800
Titre abrégé: Appl Radiat Isot
Pays: England
ID NLM: 9306253
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
24
05
2019
revised:
22
03
2020
accepted:
27
03
2020
entrez:
21
6
2020
pubmed:
21
6
2020
medline:
8
7
2021
Statut:
ppublish
Résumé
The objective of this study was to evaluate radiolabeled DOTA-SP90 as a radiotracer for breast cancer. The in vitro competition assay showed that radiolabeled DOTA-SP90 had significant binding affinity to BT-483 cancer cells. Biodistribution, nanoSPECT/CT and nanoPET/CT imaging results indicated that radiolabeled DOTA-SP90 can accumulate in tumors. In addition, radiolabeled DOTA-SP90 peptides can also detect metastatic tumors. Therefore, radiolabeled SP90 peptide may provide the potential capability as diagnostic agent for breast cancer patients.
Identifiants
pubmed: 32561130
pii: S0969-8043(20)30291-8
doi: 10.1016/j.apradiso.2020.109162
pii:
doi:
Substances chimiques
Gallium Radioisotopes
0
Heterocyclic Compounds, 1-Ring
0
Indium Radioisotopes
0
Oligopeptides
0
Radiopharmaceuticals
0
SP90 peptide
0
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
1HTE449DGZ
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
109162Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest No competing financial interests exist.